Literature DB >> 33846043

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study.

Sophia Hatziantoniou1, Helena C Maltezou2, Athanasios Tsakris3, Gregory A Poland4, Cleo Anastassopoulou5.   

Abstract

Entities:  

Keywords:  Allergy; Anaphylaxis; BNT162b2; COVID-19; Excipients; Hypersensitivity; Lipid nanoparticles (LNPs); Polyethylene glycol (PEG); SARS-CoV-2; Spike

Year:  2021        PMID: 33846043     DOI: 10.1016/j.vaccine.2021.03.073

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  11 in total

Review 1.  To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.

Authors:  Da Shi; Damian Beasock; Adam Fessler; Janos Szebeni; Julia Y Ljubimova; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Adv Drug Deliv Rev       Date:  2021-12-10       Impact factor: 15.470

Review 2.  Understanding the Role and Impact of Poly (Ethylene Glycol) (PEG) on Nanoparticle Formulation: Implications for COVID-19 Vaccines.

Authors:  Esperanza Padín-González; Pearl Lancaster; Massimo Bottini; Paolo Gasco; Lang Tran; Bengt Fadeel; Terence Wilkins; Marco P Monopoli
Journal:  Front Bioeng Biotechnol       Date:  2022-06-07

Review 3.  Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects.

Authors:  Seyed Hossein Kiaie; Naime Majidi Zolbanin; Armin Ahmadi; Rafieh Bagherifar; Hadi Valizadeh; Fatah Kashanchi; Reza Jafari
Journal:  J Nanobiotechnology       Date:  2022-06-14       Impact factor: 9.429

Review 4.  Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review.

Authors:  Uwe Wollina; Anca Chiriac; Hristina Kocic; André Koch; Piotr Brzezinski
Journal:  Wien Med Wochenschr       Date:  2021-08-23

Review 5.  The intestinal microbiota and improving the efficacy of COVID-19 vaccinations.

Authors:  Jiezhong Chen; Luis Vitetta; Jeremy D Henson; Sean Hall
Journal:  J Funct Foods       Date:  2021-11-10       Impact factor: 4.451

6.  Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant.

Authors:  Bassel Akache; Tyler M Renner; Anh Tran; Lise Deschatelets; Renu Dudani; Blair A Harrison; Diana Duque; Julie Haukenfrers; Martin A Rossotti; Francis Gaudreault; Usha D Hemraz; Edmond Lam; Sophie Régnier; Wangxue Chen; Christian Gervais; Matthew Stuible; Lakshmi Krishnan; Yves Durocher; Michael J McCluskie
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.996

7.  Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2.

Authors:  Dimitrios Tsilingiris; Natalia G Vallianou; Irene Karampela; Junli Liu; Maria Dalamaga
Journal:  Metabol Open       Date:  2021-12-17

8.  Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.

Authors:  Helena C Maltezou; Cleo Anastassopoulou; Sophia Hatziantoniou; Gregory A Poland; Athanasios Tsakris
Journal:  Vaccine       Date:  2021-11-27       Impact factor: 3.641

9.  Comparative assessment of allergic reactions to COVID-19 vaccines in Europe and the United States.

Authors:  Sophia Hatziantoniou; Cleo Anastassopoulou; Vicky Lampropoulou; Helena C Maltezou; Evangelos Andreakos; Gregory A Poland; Athanasios Tsakris
Journal:  Allergy       Date:  2022-02-24       Impact factor: 13.146

Review 10.  Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy.

Authors:  Chi Zhang; Yifan Ma; Jingjing Zhang; Jimmy Chun-Tien Kuo; Zhongkun Zhang; Haotian Xie; Jing Zhu; Tongzheng Liu
Journal:  Molecules       Date:  2022-03-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.